治疗牙周炎的Bioperio®协议的临床性能®
Filippo Graziani1, Enrica Conticini2, Laura Bettini2
1Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.
Journal of clinical medicine
|March 17, 2025
概括
Bioperio® 协议有效地管理牙周炎,改善临床参数,并实现高患者治愈率. 这种以患者为中心的方法,包括质矩阵衍生品,在牙周炎治疗中显示出有前途的结果.
科学领域:
- 牙周病学 牙周病学
- 牙科治疗学 牙科治疗学
背景情况:
- 牙周炎的管理需要标准化,以患者为中心的方法.
- Bioperio® 协议为牙周炎治疗提供了一个结构化的框架.
研究的目的:
- 评估Bioperio®协议在治疗牙周炎方面的有效性.
- 评估一个以患者为中心的框架,包括临床和非临床阶段.
主要方法:
- 这是一项多中心,单臂的观察性研究,涉及663名牙周炎患者.
- 治疗包括专业的脱皮,口腔卫生指导和脱皮/根除.
- 乳矩阵衍生物 (EMD) 用于第三阶段/第四阶段牙周炎,口袋>5毫米.
主要成果:
- 所有临床牙周参数在3个月后都得到改善.
- 实现了75.4%的口袋关闭和91.3%的患者解决.
- 补充EMD改善了结果,特别是在III期患者中.
结论:
- Bioperio® 协议是一种安全有效的牙周炎治疗方法.
- 一个逐步的方法与量身定制的患者支持提高了结果.
- 该方案显示了牙周健康的显著改善.
相关概念视频
Bioequivalence: Overview
901
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
901
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Bioavailability: Overview
2.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.6K
Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Bioremediation
18.1K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.1K
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K


